Breaking News

FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform for Bioprocessing

Adds media to support DG44 cell lines and perfusion culture platforms for the commercialization of mAbs, recombinant proteins and other biotherapeutics.

FUJIFILM Irvine Scientific, Inc., a manufacturer of cell culture solutions for life sciences, is expanding its BalanCD CHO Media Platform portfolio with the addition of two new, chemically defined growth media- BalanCD CHO Perfusion and BalanCD CHO DG44. The BalanCD CHO media portfolio is designed to ensure maximized growth, viability, and productivity of Chinese Hamster Ovary (CHO) cell lines via a scalable platform for reliable production and seamless workflow through all stages of developm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters